Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Valproic Acid Expanded Cord Blood Stem Cells as an Allogeneic Donor Source for Adults With Hematological Malignancies

NCT03885947 is registered in ClinicalTrials.gov with Alla Keyzner as lead sponsor.

NCT NCT03885947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03885947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Valproic Acid Expanded Cord Blood Stem Cells as an Allogeneic Donor Source for Adults With Hematological Malignancies
Lead sponsor
Alla Keyzner
Phase
Phase 1
Overall status
Completed
Start date
February 21, 2019
Completion date
March 10, 2021
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia in remission, acute lymphoblastic leukemia in remission, hematological malignancy, hodgkin lymphoma, myelodysplastic syndromes, non-hodgkin lymphoma